Coexpression of Human cdk5 and Its Activator p35 with Human Protein Tau in Neurons in Brain of Triple Transgenic Mice
- 28 February 2001
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 8 (1), 32-44
- https://doi.org/10.1006/nbdi.2000.0333
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5Proceedings of the National Academy of Sciences, 2000
- Cyclin-Dependent Kinase 5-Deficient Mice Demonstrate Novel Developmental Arrest in Cerebral CortexJournal of Neuroscience, 1998
- Phosphorylation of Neurofilament Heavy‐Chain Side‐Arm Fragments by Cyclin‐Dependent Kinase‐5 and Glycogen Synthase Kinase‐3α in Transfected CellsJournal of Neurochemistry, 1997
- Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lensDevelopmental Genetics, 1997
- Mice Lacking p35, a Neuronal Specific Activator of Cdk5, Display Cortical Lamination Defects, Seizures, and Adult LethalityNeuron, 1997
- Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouseJournal of Neurocytology, 1997
- AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's diseaseMolecular Brain Research, 1996
- The Xenopus laevis homologue to the neuronal cyclin-dependent kinase (cdk5) is expressed in embryos by gastrulationMolecular Brain Research, 1995
- Identification of Endogenously Phosphorylated KSP Sites in the High‐Molecular‐Weight Rat Neurofilament ProteinJournal of Neurochemistry, 1994
- Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5FEBS Letters, 1993